Collegium Pharmaceutical (COLL) Inventory Average (2016 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Inventory Average of $41.8 million for Q1 2026, up 14.94% year-over-year from $36.4 million in Q1 2025, and up 5.94% quarter-over-quarter from $39.5 million in Q4 2025.
Collegium Pharmaceutical (COLL) Inventory Average (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's Inventory Average history runs 11 years deep, the most recent figure standing at $41.8 million for Q1 2026.
- In Q1 2026, Inventory Average rose 14.94% year-over-year to $41.8 million; the TTM figure through Mar 2026 stood at $41.8 million (up 14.94% YoY), while the FY2025 annual figure was $38.2 million, up 12.64% from the prior year.
- Inventory Average for Q1 2026 stood at $41.8 million, up from $39.5 million in the prior quarter.
- The five-year high for Inventory Average was $79.0 million in Q2 2022, with the low at $29.5 million in Q2 2023.
- The 5-year median for Inventory Average is $37.7 million (2025), against an average of $41.9 million.
- The sharpest annual moves came in 2022 and 2023: Inventory Average soared 349.99% in 2022, then sank 62.69% in 2023.
- Collegium Pharmaceutical's Inventory Average stood at $55.6 million in 2022, then tumbled by 40.21% to $33.2 million in 2023, then grew by 10.74% to $36.8 million in 2024, then rose by 7.3% to $39.5 million in 2025, then gained by 5.94% to $41.8 million in 2026.
- Business Quant data shows COLL's Inventory Average at $41.8 million in Q1 2026, $39.5 million in Q4 2025, and $38.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | 78.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 78.01 Mn |
| Mar 31, 2026 | 41.83 Mn |
| Dec 31, 2025 | 39.48 Mn |
| Sep 30, 2025 | 38.10 Mn |
| Jun 30, 2025 | 37.68 Mn |
| Mar 31, 2025 | 36.39 Mn |
| Dec 31, 2024 | 36.80 Mn |
| Sep 30, 2024 | 32.95 Mn |
| Jun 30, 2024 | 29.57 Mn |
| Mar 31, 2024 | 31.80 Mn |
| Dec 31, 2023 | 33.23 Mn |
| Sep 30, 2023 | 30.08 Mn |
| Jun 30, 2023 | 29.46 Mn |
| Mar 31, 2023 | 39.70 Mn |
| Dec 31, 2022 | 55.58 Mn |
| Sep 30, 2022 | 71.21 Mn |
| Jun 30, 2022 | 78.96 Mn |
| Mar 31, 2022 | 48.77 Mn |
| Dec 31, 2021 | 17.38 Mn |
| Sep 30, 2021 | 18.48 Mn |